US faces lab monkey scarcity amid Cambodia smuggling scandal

Scientists have urged the US authorities to extend funding in lab monkey breeding programmes as a smuggling scandal in Cambodia dangers worsening a scarcity of take a look at animals that’s hurting the life sciences sector.

Teachers pursuing some research already face delays of as much as a 12 months as a result of issue in sourcing so referred to as non-human primates, which regulators insist are vital to show the protection of medication in early analysis.

Surging demand for lab monkeys throughout Covid-19, a ban on exports from China and underfunding of home breeding programmes within the US have disrupted the NHP provide chain and induced costs to triple, based on business specialists.

Two of the most important suppliers of lab monkeys to the pharmaceutical business, US-listed Charles River and Inotiv, just lately warned traders they count on disruption to US imports from Cambodia, the nation’s largest provider of NHPs.

It follows the indictment by Federal prosecutors final month of eight folks — together with two senior Cambodian authorities officers — who had been allegedly concerned in working a smuggling ring which illegally exported wild monkeys to the US for analysis functions.

One of many Cambodian officers was arrested at John F Kennedy Worldwide Airport, prompting Phnom Penh to declare the arrest “unjustified”.

A Cambodian official instructed the Monetary Occasions it has not imposed a ban on exports to the US. However the case has heightened business issues in regards to the nation’s reliance on imports at a time when some analysis programmes face year-long delays resulting from a scarcity of monkeys.

“If corporations and tutorial researchers can’t get the non-human primate [monkeys] analysis fashions they want — then the work stops. You’ll be able to say goodbye to new vaccines and medicines,” stated Matthew Bailey, president on the Nationwide Affiliation for Biomedical Analysis, an business group.

“It’s of essential significance to public well being and nationwide safety.”

Bailey stated Washington ought to discover public non-public partnerships and different funding choices to spice up home breeding.

Provides of the preferred monkey species utilized by pharmaceutical corporations for analysis, long-tailed macaques, have been strained for a number of years resulting from robust demand from researchers and restricted US-based breeding programmes.

A 2020 export ban levied by China — which on the time was the most important provider to the US — throughout Covid-19 induced the worth of lab monkeys to triple between 2019-22, based on analysis by Evercore ISI.

Evercore estimates the common costs of lab monkeys in 2019-20 was between $4,000-$7,000. In 2020-21 this elevated to $10,000 and in 2021-22 it elevated once more to between $20,000-$24,000. Evercore forecasts costs will rise once more to $30,000-$35,000 in 2023.

Elizabeth Anderson, an analyst at Evercore, stated massive pharma corporations usually are not usually delicate to NHP pricing however over the long-term excessive costs and provide disruption may immediate them to put money into their very own breeding amenities fairly than depend on imports.

Specialists say tutorial researchers and smaller biotechs are extra susceptible to shortages and worth rises of lab monkeys, which regulators insist are vital to show the protection of medication in early research.

Teachers can supply animals from seven nationwide primate analysis centres, that are US-based breeding amenities funded by the Nationwide Institutes of Well being. However the centres, which collectively have about 20,000-25,000 animals, say they don’t have sufficient animals to fulfill demand and wish extra funding, the administrators of two amenities instructed the FT. 

“We’re greater than a 12 months behind in a lot of our research. Personally, I’ve one grant that had not been capable of assign animals to for greater than a 12 months,” stated Professor Nancy Haigwood, director of the Oregon Nationwide Primate Analysis Middle.

Skip Bohm, affiliate director of the Tulane Nationwide Primate Analysis Middle, stated an audit of analysis requests throughout the seven US centres confirmed they had been 3,000 animals brief in 2021.

“Over the previous decade, we’ve sort of bridged the hole and put band-aids on the scenario, however . . . if it continues on this approach. We’re actually nervous that we’re going to need to cease some research,” he stated.

The Nationwide Institutes of Well being stated there’s an ongoing problem to produce an satisfactory provide of NHPs for biomedical analysis as a result of scarcity however condemned all unlawful commerce of animals.

“Any answer . . . have to be finished so in accordance with animal welfare-related insurance policies and compliance oversight procedures in accordance with the federal legal guidelines, laws, and insurance policies.”

In July the Worldwide Union for Conservation of Nature listed long-tailed macaques for the primary time as “endangered”, partly resulting from skyrocketing demand for the species in medical analysis.

Peta, an animal rights group, stated researchers’ reliance on lab monkeys was outdated as there are significantly better human-relevant analysis strategies accessible.

Lisa Jones-Engel, Peta’s senior science adviser, stated US scientists had by no means been profitable at breeding advanced, delicate monkeys with out appallingly excessive demise charges.

“That’s why they’ve been prepared to purchase animals kidnapped from their very own houses in Asia, Africa and South America . . . We’ve got to cease the monkey experimenters from hijacking the funds wanted to implement them.”

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles